Chime Financial, Inc. Class A Common Stock (CHYM) Earnings Analysis
Chime Financial, Inc. Class A Common Stock (CHYM) has no confirmed upcoming earnings date. Last quarter (2026-02-25) it beat with EPS -0.12 USD vs -0.2 USD est (+40%). It has beaten estimates in 1/2 recent quarters (50%). Trailing P/E -8.33.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does CHYM next report earnings?
No confirmed upcoming earnings date is currently scheduled for CHYM. This page updates as the calendar is published.
CHYM earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-25 | -0.12 USD | -0.2 USD | +40% | Beat |
| 2025-08-07 | -7.29 USD | -4.85 USD | -50.3% | Miss |
| 2025-03-31 | 0.03551 USD | n/a | n/a | n/a |
| 2024-12-30 | -0.0538 USD | n/a | n/a | n/a |
| 2024-09-29 | -0.06044 USD | n/a | n/a | n/a |
Beat rate: 1/2 (50%) over reported quarters with consensus data.
CHYM valuation and analyst view
| Trailing P/E | -8.33 |
|---|---|
| Trailing EPS | -2.54016 USD |
| Price / book | 5.78 |
| Dividend yield | 0.00% |
| Market cap | 8.32B |
| Analyst consensus | Buy (8 buy / 1 hold / 0 sell) |
| Avg price target | 28.33 USD |
Related research pages
Frequently asked questions
When is Chime Financial, Inc. Class A Common Stock (CHYM)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for CHYM. This page updates as the calendar is published.
Did CHYM beat earnings last quarter?
In its 2026-02-25 report, CHYM posted EPS of -0.12 USD versus a -0.2 USD estimate — a beat of 40%.
What is CHYM's earnings track record?
Over the last 2 reported quarters with consensus data, CHYM beat estimates 1 times (50%).
What is CHYM's current P/E ratio and EPS?
CHYM trades at a trailing P/E of -8.33 on trailing EPS of -2.5401604226341625 USD.
What do analysts rate CHYM?
Analyst consensus is "Buy" across 9 ratings (0 strong buy, 8 buy, 1 hold, 0 sell, 0 strong sell). Average 12-month price target: 28.33 USD.